Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BAX: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
BAX is a gene implicated in neurodegeneration research. Key relationships include: activates, inhibits, associated with. Associated with ALS, ALZHEIMER'S DISEASE, Aging. Connected to 1233 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | BAX |
| Chromosome | 19q13.33 |
| Protein Family | BCL-2 family (BH3-only pro-apoptotic) |
| Function | is a critical pro-apoptotic member of the BCL-2 protein family that plays a central role in regulating mitochondrial apoptosis. |
| Subcellular Localization | Cytosol (inactive), Mitochondria (active), ER |
| Molecular Weight | 21 kDa (192 amino acids) |
| Amino Acids | 192 aa |
| Pathways | Akt, Apoptosis, Autophagy, Cell Division, Cholesterol |
| UniProt ID | Q07812 |
| Ensembl ID | ENSG00000087088 |
| GeneCards | BAX |
| Human Protein Atlas | BAX |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease, Ataxia |
| Known Drugs/Compounds | ABT-263, ANTHOCYANINS, berberine, BERBERINE, B.glomerulata, cadmium |
| Interactions | ABCG2, ACHE, ACSL4, ADAM8, AGING, AIF |
| KG Connections | 2405 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
BAX["BAX
(Pro-apoptotic Protein)"]
subgraph Regulators["Regulatory Inputs"]
LRWE["LRWE
(Regulator)"]
gallic["Gallic Acid
(Compound)"]
cadmium["Cadmium
(Heavy Metal)"]
magnolol["Magnolol
(Compound)"]
tirzepatide["Tirzepatide
(Drug)"]
end
subgraph CorePathways["Core Molecular Functions"]
apoptosis["Apoptosis
(Cell Death)"]
bcl2["BCL2
(Anti-apoptotic Protein)"]
end
subgraph DiseaseProtection["Disease Protection/Inhibition"]
cancer["Cancer"]
als["ALS
(Amyotrophic Lateral Sclerosis)"]
aging["Aging"]
hf["Heart Failure"]
inflammation["Inflammation"]
hepatitis["Hepatitis"]
fibrosis["Fibrosis"]
end
subgraph DiseaseAssociation["Disease Association/Activation"]
lymphoma["Lymphoma"]
ms["Multiple Sclerosis"]
end
LRWE -->|"regulates
0.8"| BAX
gallic -->|"associated_with
0.9"| BAX
cadmium -->|"inhibits
0.7"| BAX
magnolol -->|"inhibits
0.7"| BAX
tirzepatide -->|"inhibits
0.7"| BAX
BAX -->|"activates
0.9"| apoptosis
BAX -->|"interacts_with
0.7"| bcl2
BAX -->|"inhibits
0.65"| cancer
BAX -->|"inhibits
0.65"| als
BAX -->|"inhibits
0.65"| aging
BAX -->|"inhibits
0.65"| hf
BAX -->|"inhibits
0.65"| inflammation
BAX -->|"inhibits
0.65"| hepatitis
BAX -->|"inhibits
0.65"| fibrosis
BAX -->|"associated_with
0.65"| lymphoma
BAX -->|"associated_with
0.65"| ms
classDef mainGene fill:#ff6b6b,stroke:#c92a2a,stroke-width:3px,color:#e0e0e0
classDef protein fill:#4ecdc4,stroke:#0a9396,stroke-width:2px,color:#e0e0e0
classDef compound fill:#95e1d3,stroke:#38ada9,stroke-width:2px,color:#e0e0e0
classDef process fill:#ffd93d,stroke:#ffb703,stroke-width:2px,color:#e0e0e0
classDef disease fill:#a8e6cf,stroke:#56ab91,stroke-width:2px,color:#e0e0e0
classDef diseaseNeg fill:#ff8b94,stroke:#d62828,stroke-width:2px,color:#e0e0e0
class BAX mainGene
class bcl2,LRWE protein
class gallic,cadmium,magnolol,tirzepatide compound
class apoptosis process
class cancer,als,aging,hf,inflammation,hepatitis,fibrosis disease
class lymphoma,ms diseaseNeg| Target | Relation | Type | Str |
|---|---|---|---|
| INFLAMMATION | activates | gene | 1.00 |
| APOPTOSIS | expressed_in | gene | 1.00 |
| Lymphoma | regulates | disease | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| DNA | activates | gene | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Aging | activates | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| APOPTOSIS | inhibits | gene | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Apoptosis | regulates | pathway | 1.00 |
| AKT | activates | gene | 1.00 |
| Apoptosis | inhibits | pathway | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| P53 | activates | gene | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Cardiac | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| GENES | activates | gene | 1.00 |
| CASP3 | associated_with | gene | 1.00 |
| BCL-2 | expressed_in | gene | 1.00 |
| Stem Cell | activates | pathway | 1.00 |
| Invasion | activates | pathway | 1.00 |
| MITOCHONDRIA | activates | gene | 1.00 |
| Als | inhibits | disease | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Mtor | activates | pathway | 1.00 |
| Cancer | activates | disease | 1.00 |
| ROS | activates | gene | 1.00 |
| MTOR | activates | gene | 1.00 |
| Apoptosis | expressed_in | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Als | associated_with | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| BCL-2 | activates | gene | 1.00 |
| Pi3K/Akt | activates | pathway | 1.00 |
| APOPTOSIS | regulates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| BCL-2 | inhibits | gene | 1.00 |
| Cell Cycle | activates | pathway | 1.00 |
| TNF | activates | gene | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| TNF-Α | activates | gene | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOPTOSIS | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| APOPTOSIS | inhibits | gene | 0.98 |
| APOPTOSIS | activates | gene | 0.98 |
| T3 | downregulates | drug | 0.95 |
| T3 | inhibits | drug | 0.95 |
| HB68 | upregulates | compound | 0.93 |
| HB147 | upregulates | compound | 0.93 |
| gallic acid | associated_with | drug | 0.90 |
| Rotenone | upregulates | compound | 0.90 |
| Copper | upregulates | compound | 0.90 |
| AMYLOID | associated_with | protein | 0.90 |
| cardamom nanoemulsion | upregulates | compound | 0.90 |
| ASPP1 | upstream_of | protein | 0.90 |
| B.glomerulata | inhibits | drug | 0.90 |
| JAK2/STAT3 Signaling Pathway | downregulates | pathway | 0.87 |
| melamine | upregulates | compound | 0.87 |
| SQDS | downregulates | drug | 0.85 |
| TP53 | upstream_of | gene | 0.85 |
| SQDS | inhibits | drug | 0.85 |
| MTOR | regulates | entity | 0.85 |
| venetoclax | activates | drug | 0.85 |
| AKR1B10 | regulates | gene | 0.85 |
| Oxidative Stress | upregulates | process | 0.85 |
| PI3K/AKT/mTOR | inhibits | pathway | 0.85 |
| unfolded protein response | upregulates | process | 0.85 |
| sh-AKR1B10 | modulates | gene | 0.82 |
| TP53 | activates | entity | 0.82 |
| Asiatic acid | downregulates | compound | 0.80 |
| AE | downregulates | compound | 0.80 |
| GINSENOSIDE_RO | downregulates | compound | 0.80 |
| BAD | interacts_with | protein | 0.80 |
| ANTHOCYANINS | inhibits | compound | 0.80 |
| DHT | regulates | compound | 0.80 |
| LRWE | regulates | drug | 0.80 |
| BCL-2 | inhibits | gene | 0.80 |
| TP53 | upregulates | gene | 0.80 |
| TNF | activates | gene | 0.80 |
| ROS | activates | gene | 0.80 |
| LPS | activates | drug | 0.75 |
| PI3K/AKT signaling pathway | regulates | pathway | 0.75 |
| Mifepristone | modulates | drug | 0.75 |
| BCL-2 | activates | gene | 0.70 |
| TP53 | regulates | gene | 0.70 |
| BCL-2 | expressed_in | gene | 0.70 |
| Gallic acid | inhibits | drug | 0.70 |
| BCL-2 | interacts_with | gene | 0.70 |
| BCL-2 | therapeutic_target | gene | 0.70 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.70 |
| JUN | activates | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.921
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning BAX in their description or question text
No additional research found